

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cardiac myofibril assembly (GO:0055003) | 9.50679356 |
| 2 | sarcomere organization (GO:0045214) | 8.66867286 |
| 3 | myofibril assembly (GO:0030239) | 7.89838426 |
| 4 | cardiac muscle contraction (GO:0060048) | 7.20432601 |
| 5 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 7.13557673 |
| 6 | actin-myosin filament sliding (GO:0033275) | 7.10641060 |
| 7 | muscle filament sliding (GO:0030049) | 7.10641060 |
| 8 | regulation of relaxation of muscle (GO:1901077) | 6.88787942 |
| 9 | cardiac muscle cell development (GO:0055013) | 6.74121486 |
| 10 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 6.73209942 |
| 11 | cardiac muscle tissue morphogenesis (GO:0055008) | 6.62651056 |
| 12 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 6.57527774 |
| 13 | tricarboxylic acid cycle (GO:0006099) | 6.56565047 |
| 14 | cardiac muscle hypertrophy (GO:0003300) | 6.50267863 |
| 15 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 6.46980363 |
| 16 | cardiac cell development (GO:0055006) | 6.35173170 |
| 17 | heart contraction (GO:0060047) | 6.19109252 |
| 18 | heart process (GO:0003015) | 6.19109252 |
| 19 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 6.17097401 |
| 20 | striated muscle hypertrophy (GO:0014897) | 6.12783517 |
| 21 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 6.12129829 |
| 22 | actin-mediated cell contraction (GO:0070252) | 6.04746289 |
| 23 | regulation of actin filament-based movement (GO:1903115) | 5.91826602 |
| 24 | muscle tissue morphogenesis (GO:0060415) | 5.91594569 |
| 25 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 5.91571465 |
| 26 | actomyosin structure organization (GO:0031032) | 5.91305536 |
| 27 | regulation of sarcomere organization (GO:0060297) | 5.77073517 |
| 28 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 5.75923107 |
| 29 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 5.72709695 |
| 30 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 5.65720666 |
| 31 | ATP synthesis coupled proton transport (GO:0015986) | 5.65720666 |
| 32 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 5.55513400 |
| 33 | ventricular cardiac muscle cell action potential (GO:0086005) | 5.47089332 |
| 34 | oxidative phosphorylation (GO:0006119) | 5.45961014 |
| 35 | muscle hypertrophy (GO:0014896) | 5.44879296 |
| 36 | heart trabecula formation (GO:0060347) | 5.40052377 |
| 37 | regulation of cell communication by electrical coupling (GO:0010649) | 5.34089023 |
| 38 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 5.27926619 |
| 39 | striated muscle contraction (GO:0006941) | 5.24543583 |
| 40 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 5.05798838 |
| 41 | adult heart development (GO:0007512) | 5.04195253 |
| 42 | respiratory electron transport chain (GO:0022904) | 5.01956857 |
| 43 | regulation of the force of heart contraction (GO:0002026) | 4.99046287 |
| 44 | electron transport chain (GO:0022900) | 4.88362329 |
| 45 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.85975363 |
| 46 | adrenergic receptor signaling pathway (GO:0071875) | 4.81351259 |
| 47 | regulation of striated muscle contraction (GO:0006942) | 4.79361838 |
| 48 | cardiac ventricle formation (GO:0003211) | 4.78812992 |
| 49 | cell communication involved in cardiac conduction (GO:0086065) | 4.75514560 |
| 50 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.74966263 |
| 51 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 4.73172772 |
| 52 | regulation of skeletal muscle contraction (GO:0014819) | 4.72260100 |
| 53 | regulation of coenzyme metabolic process (GO:0051196) | 4.70051970 |
| 54 | regulation of cofactor metabolic process (GO:0051193) | 4.70051970 |
| 55 | detection of calcium ion (GO:0005513) | 4.69940966 |
| 56 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.58647098 |
| 57 | cell communication by electrical coupling (GO:0010644) | 4.53634823 |
| 58 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 4.52156188 |
| 59 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 4.48824003 |
| 60 | regulation of cardioblast differentiation (GO:0051890) | 4.46954567 |
| 61 | actin filament-based movement (GO:0030048) | 4.46855808 |
| 62 | response to caffeine (GO:0031000) | 4.45354338 |
| 63 | carnitine shuttle (GO:0006853) | 4.42006926 |
| 64 | negative regulation of striated muscle cell apoptotic process (GO:0010664) | 4.40427431 |
| 65 | relaxation of cardiac muscle (GO:0055119) | 4.40081727 |
| 66 | regulation of membrane repolarization (GO:0060306) | 4.26493861 |
| 67 | cardiac muscle adaptation (GO:0014887) | 4.25256289 |
| 68 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 4.25256289 |
| 69 | muscle hypertrophy in response to stress (GO:0003299) | 4.25256289 |
| 70 | cellular response to epinephrine stimulus (GO:0071872) | 4.23314886 |
| 71 | response to epinephrine (GO:0071871) | 4.20510521 |
| 72 | regulation of cardiac muscle cell contraction (GO:0086004) | 4.19851153 |
| 73 | ventricular cardiac muscle cell development (GO:0055015) | 4.14781603 |
| 74 | relaxation of muscle (GO:0090075) | 4.09480572 |
| 75 | plasma membrane repair (GO:0001778) | 4.04533084 |
| 76 | regulation of cardiac muscle contraction (GO:0055117) | 4.03860287 |
| 77 | positive regulation of cardiac muscle cell differentiation (GO:2000727) | 4.03560794 |
| 78 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 4.03397399 |
| 79 | cardiac muscle cell action potential (GO:0086001) | 4.03114208 |
| 80 | fatty acid transmembrane transport (GO:1902001) | 3.98610960 |
| 81 | cardiac conduction (GO:0061337) | 3.98322535 |
| 82 | regulation of heart rate (GO:0002027) | 3.91817878 |
| 83 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.90179096 |
| 84 | regulation of sulfur metabolic process (GO:0042762) | 3.77870546 |
| 85 | regulation of ATPase activity (GO:0043462) | 3.76857082 |
| 86 | regulation of ATP catabolic process (GO:1903289) | 3.76857082 |
| 87 | regulation of heart rate by cardiac conduction (GO:0086091) | 3.73642611 |
| 88 | ATP biosynthetic process (GO:0006754) | 3.72974627 |
| 89 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.67345160 |
| 90 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.67345160 |
| 91 | positive regulation of heart contraction (GO:0045823) | 3.66645295 |
| 92 | negative regulation of hormone biosynthetic process (GO:0032353) | 3.65142376 |
| 93 | striated muscle cell development (GO:0055002) | 3.62676228 |
| 94 | sequestering of extracellular ligand from receptor (GO:0035581) | 3.56920661 |
| 95 | regulation of heart contraction (GO:0008016) | 3.51876815 |
| 96 | atrioventricular valve morphogenesis (GO:0003181) | 3.51040040 |
| 97 | trabecula formation (GO:0060343) | 3.48787579 |
| 98 | positive regulation of ATPase activity (GO:0032781) | 3.46457240 |
| 99 | positive regulation of ATP catabolic process (GO:1903291) | 3.46457240 |
| 100 | negative regulation of protein localization to cell surface (GO:2000009) | 3.46082450 |
| 101 | atrial septum morphogenesis (GO:0060413) | 3.42284660 |
| 102 | regulation of striated muscle cell apoptotic process (GO:0010662) | 3.39772873 |
| 103 | outflow tract septum morphogenesis (GO:0003148) | 3.36749340 |
| 104 | regulation of muscle contraction (GO:0006937) | 3.34603426 |
| 105 | negative regulation of potassium ion transport (GO:0043267) | 3.33914505 |
| 106 | cardiac muscle tissue development (GO:0048738) | 3.33556047 |
| 107 | regulation of muscle system process (GO:0090257) | 3.30986076 |
| 108 | pericardium development (GO:0060039) | 3.30169979 |
| 109 | desmosome organization (GO:0002934) | 3.29811093 |
| 110 | positive regulation of cardiac muscle tissue development (GO:0055025) | 3.29635599 |
| 111 | gap junction assembly (GO:0016264) | 3.29078143 |
| 112 | succinate metabolic process (GO:0006105) | 3.27831161 |
| 113 | positive regulation of cardiac muscle tissue growth (GO:0055023) | 3.27192960 |
| 114 | cardiac chamber formation (GO:0003207) | 3.24587649 |
| 115 | positive regulation of heart rate (GO:0010460) | 3.23331824 |
| 116 | positive regulation of cation channel activity (GO:2001259) | 3.23172594 |
| 117 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.21780300 |
| 118 | muscle contraction (GO:0006936) | 3.20543984 |
| 119 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 3.20013463 |
| 120 | positive regulation of sodium ion transport (GO:0010765) | 3.19766347 |
| 121 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.18862281 |
| 122 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.18862281 |
| 123 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.18257644 |
| 124 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.17227184 |
| 125 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.17178226 |
| 126 | muscle cell development (GO:0055001) | 3.15554039 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 7.12414477 |
| 2 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 6.68317538 |
| 3 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 5.13696520 |
| 4 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 4.99074833 |
| 5 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 4.41498242 |
| 6 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 4.16728727 |
| 7 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 4.16728727 |
| 8 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 3.91706111 |
| 9 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.77041948 |
| 10 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 3.11756841 |
| 11 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.99140078 |
| 12 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.90092081 |
| 13 | GATA1_22025678_ChIP-Seq_K562_Human | 2.72966806 |
| 14 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.72011034 |
| 15 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 2.48859724 |
| 16 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.38823125 |
| 17 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.18063141 |
| 18 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.14401262 |
| 19 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 2.09773861 |
| 20 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 2.03578396 |
| 21 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 2.02103140 |
| 22 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.01129831 |
| 23 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.96603719 |
| 24 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.87667710 |
| 25 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.85444396 |
| 26 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.81480685 |
| 27 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.75574695 |
| 28 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.72046717 |
| 29 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.70111232 |
| 30 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.70071596 |
| 31 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.67660444 |
| 32 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.63151629 |
| 33 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.61751656 |
| 34 | FUS_26573619_Chip-Seq_HEK293_Human | 1.60288374 |
| 35 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.56625535 |
| 36 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.55524995 |
| 37 | TCF4_23295773_ChIP-Seq_U87_Human | 1.54251870 |
| 38 | STAT3_23295773_ChIP-Seq_U87_Human | 1.54189882 |
| 39 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.52643788 |
| 40 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.52415292 |
| 41 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.51743969 |
| 42 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.51583708 |
| 43 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.51095632 |
| 44 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.50984737 |
| 45 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.50426936 |
| 46 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.46447586 |
| 47 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.45782544 |
| 48 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.43145538 |
| 49 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.42179986 |
| 50 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.41939201 |
| 51 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.39120408 |
| 52 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.37161321 |
| 53 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.36544730 |
| 54 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.36205588 |
| 55 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.32977568 |
| 56 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.32958112 |
| 57 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.32393730 |
| 58 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.30095955 |
| 59 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.26935076 |
| 60 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.24575969 |
| 61 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.22167995 |
| 62 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.21538028 |
| 63 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.21134402 |
| 64 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.20624085 |
| 65 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.19812509 |
| 66 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.18733310 |
| 67 | EWS_26573619_Chip-Seq_HEK293_Human | 1.17275054 |
| 68 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.17169785 |
| 69 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.16688022 |
| 70 | CJUN_26792858_Chip-Seq_BT549_Human | 1.15079560 |
| 71 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.13857953 |
| 72 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.13593870 |
| 73 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.11827916 |
| 74 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.11228230 |
| 75 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.11097956 |
| 76 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.10586964 |
| 77 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.10427442 |
| 78 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.10364075 |
| 79 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.10303654 |
| 80 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.08338809 |
| 81 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.07616741 |
| 82 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.07511696 |
| 83 | * AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.07239898 |
| 84 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.05816446 |
| 85 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.04691773 |
| 86 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.04641683 |
| 87 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.04408106 |
| 88 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.03981119 |
| 89 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.03501524 |
| 90 | * SOX9_26525672_Chip-Seq_HEART_Mouse | 1.02671972 |
| 91 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.99971919 |
| 92 | * TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.99230768 |
| 93 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.98697554 |
| 94 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.97463346 |
| 95 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.96451730 |
| 96 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.96432033 |
| 97 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.95363576 |
| 98 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.95082557 |
| 99 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.94949752 |
| 100 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.94896882 |
| 101 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.92262844 |
| 102 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.91479658 |
| 103 | VDR_22108803_ChIP-Seq_LS180_Human | 0.90549975 |
| 104 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.90098682 |
| 105 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.89890689 |
| 106 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.88378566 |
| 107 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.86828642 |
| 108 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.86225488 |
| 109 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.84989165 |
| 110 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.83839042 |
| 111 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.83517562 |
| 112 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.83306207 |
| 113 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.83299712 |
| 114 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.83248065 |
| 115 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.81080807 |
| 116 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.79617649 |
| 117 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.79154804 |
| 118 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.79070291 |
| 119 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.78341661 |
| 120 | GATA1_19941826_ChIP-Seq_K562_Human | 0.78205636 |
| 121 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.77482598 |
| 122 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.77466734 |
| 123 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.77466734 |
| 124 | TP53_16413492_ChIP-PET_HCT116_Human | 0.76056385 |
| 125 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.75846593 |
| 126 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.75340792 |
| 127 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.73547194 |
| 128 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.72864824 |
| 129 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.71216393 |
| 130 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.69733303 |
| 131 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.69733303 |
| 132 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.68889437 |
| 133 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.68287401 |
| 134 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.66755366 |
| 135 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.66640986 |
| 136 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.66450941 |
| 137 | TBL1_22424771_ChIP-Seq_293T_Human | 0.64458148 |
| 138 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.63126758 |
| 139 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.62959140 |
| 140 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.62931210 |
| 141 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.62649343 |
| 142 | CBP_21632823_ChIP-Seq_H3396_Human | 0.62205417 |
| 143 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.61371477 |
| 144 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.61225624 |
| 145 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.61214551 |
| 146 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.60336700 |
| 147 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.59879207 |
| 148 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.58895201 |
| 149 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.58677686 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004084_abnormal_cardiac_muscle | 6.45478036 |
| 2 | MP0002837_dystrophic_cardiac_calcinosis | 5.15451906 |
| 3 | MP0003646_muscle_fatigue | 4.85869750 |
| 4 | MP0004215_abnormal_myocardial_fiber | 4.70891277 |
| 5 | MP0000749_muscle_degeneration | 4.40960826 |
| 6 | MP0004036_abnormal_muscle_relaxation | 4.35811800 |
| 7 | MP0000751_myopathy | 4.20695000 |
| 8 | MP0005330_cardiomyopathy | 4.13577048 |
| 9 | MP0002972_abnormal_cardiac_muscle | 3.54779268 |
| 10 | MP0008775_abnormal_heart_ventricle | 3.44805871 |
| 11 | MP0004484_altered_response_of | 3.09095330 |
| 12 | MP0004087_abnormal_muscle_fiber | 3.07899855 |
| 13 | MP0003137_abnormal_impulse_conducting | 3.05105759 |
| 14 | MP0001544_abnormal_cardiovascular_syste | 2.89945687 |
| 15 | MP0005385_cardiovascular_system_phenoty | 2.89945687 |
| 16 | MP0010630_abnormal_cardiac_muscle | 2.87694009 |
| 17 | MP0005620_abnormal_muscle_contractility | 2.82860274 |
| 18 | MP0006138_congestive_heart_failure | 2.78728610 |
| 19 | MP0003221_abnormal_cardiomyocyte_apopto | 2.74786415 |
| 20 | MP0004510_myositis | 2.59811151 |
| 21 | MP0004085_abnormal_heartbeat | 2.46297713 |
| 22 | MP0002106_abnormal_muscle_physiology | 2.43381020 |
| 23 | MP0004145_abnormal_muscle_electrophysio | 2.38532023 |
| 24 | MP0003828_pulmonary_edema | 2.37858453 |
| 25 | MP0004130_abnormal_muscle_cell | 2.20210143 |
| 26 | MP0002127_abnormal_cardiovascular_syste | 2.16763982 |
| 27 | MP0000750_abnormal_muscle_regeneration | 2.15266401 |
| 28 | MP0002269_muscular_atrophy | 2.10452147 |
| 29 | MP0006036_abnormal_mitochondrial_physio | 1.98630384 |
| 30 | MP0003567_abnormal_fetal_cardiomyocyte | 1.96192017 |
| 31 | MP0005369_muscle_phenotype | 1.93430255 |
| 32 | MP0004233_abnormal_muscle_weight | 1.80731171 |
| 33 | MP0000747_muscle_weakness | 1.75351775 |
| 34 | MP0002102_abnormal_ear_morphology | 1.66347212 |
| 35 | MP0000759_abnormal_skeletal_muscle | 1.65293907 |
| 36 | MP0003950_abnormal_plasma_membrane | 1.65101229 |
| 37 | MP0005451_abnormal_body_composition | 1.44641342 |
| 38 | MP0002332_abnormal_exercise_endurance | 1.37598992 |
| 39 | MP0000266_abnormal_heart_morphology | 1.32331281 |
| 40 | MP0001661_extended_life_span | 1.29961839 |
| 41 | MP0010368_abnormal_lymphatic_system | 1.23227474 |
| 42 | MP0005165_increased_susceptibility_to | 1.20828882 |
| 43 | MP0006035_abnormal_mitochondrial_morpho | 1.15921579 |
| 44 | MP0003122_maternal_imprinting | 1.14315925 |
| 45 | MP0000343_altered_response_to | 1.10467283 |
| 46 | MP0009384_cardiac_valve_regurgitation | 1.07093848 |
| 47 | MP0000230_abnormal_systemic_arterial | 1.01817862 |
| 48 | MP0004272_abnormal_basement_membrane | 0.96837891 |
| 49 | MP0003045_fibrosis | 0.94715424 |
| 50 | MP0002128_abnormal_blood_circulation | 0.88481363 |
| 51 | MP0005666_abnormal_adipose_tissue | 0.87154318 |
| 52 | MP0003279_aneurysm | 0.86063806 |
| 53 | MP0003566_abnormal_cell_adhesion | 0.85707827 |
| 54 | MP0005248_abnormal_Harderian_gland | 0.81229058 |
| 55 | MP0001879_abnormal_lymphatic_vessel | 0.78367283 |
| 56 | MP0000462_abnormal_digestive_system | 0.78315340 |
| 57 | MP0005266_abnormal_metabolism | 0.74097562 |
| 58 | MP0003941_abnormal_skin_development | 0.70289276 |
| 59 | MP0005670_abnormal_white_adipose | 0.69902242 |
| 60 | MP0003937_abnormal_limbs/digits/tail_de | 0.69837423 |
| 61 | MP0001984_abnormal_olfaction | 0.68734883 |
| 62 | MP0002234_abnormal_pharynx_morphology | 0.68499406 |
| 63 | MP0000767_abnormal_smooth_muscle | 0.66781721 |
| 64 | MP0003984_embryonic_growth_retardation | 0.64667676 |
| 65 | MP0002088_abnormal_embryonic_growth/wei | 0.64496869 |
| 66 | MP0002925_abnormal_cardiovascular_devel | 0.62924669 |
| 67 | MP0003806_abnormal_nucleotide_metabolis | 0.62388573 |
| 68 | MP0004043_abnormal_pH_regulation | 0.58560055 |
| 69 | MP0009250_abnormal_appendicular_skeleto | 0.57014990 |
| 70 | MP0002108_abnormal_muscle_morphology | 0.56753973 |
| 71 | MP0005623_abnormal_meninges_morphology | 0.56523756 |
| 72 | MP0002638_abnormal_pupillary_reflex | 0.51731209 |
| 73 | MP0001784_abnormal_fluid_regulation | 0.50542973 |
| 74 | MP0003136_yellow_coat_color | 0.48300575 |
| 75 | MP0008004_abnormal_stomach_pH | 0.47949417 |
| 76 | MP0001614_abnormal_blood_vessel | 0.46664112 |
| 77 | MP0005375_adipose_tissue_phenotype | 0.46257156 |
| 78 | MP0005253_abnormal_eye_physiology | 0.45959365 |
| 79 | MP0005187_abnormal_penis_morphology | 0.44179256 |
| 80 | MP0002168_other_aberrant_phenotype | 0.44152834 |
| 81 | MP0004147_increased_porphyrin_level | 0.44140129 |
| 82 | MP0003121_genomic_imprinting | 0.43190477 |
| 83 | MP0002909_abnormal_adrenal_gland | 0.42933785 |
| 84 | MP0006072_abnormal_retinal_apoptosis | 0.40972868 |
| 85 | MP0000733_abnormal_muscle_development | 0.40963014 |
| 86 | MP0005595_abnormal_vascular_smooth | 0.40455402 |
| 87 | MP0001672_abnormal_embryogenesis/_devel | 0.40284311 |
| 88 | MP0005380_embryogenesis_phenotype | 0.40284311 |
| 89 | MP0005503_abnormal_tendon_morphology | 0.39057005 |
| 90 | MP0003123_paternal_imprinting | 0.38919678 |
| 91 | MP0003948_abnormal_gas_homeostasis | 0.37967986 |
| 92 | MP0002009_preneoplasia | 0.35579806 |
| 93 | MP0005085_abnormal_gallbladder_physiolo | 0.35225674 |
| 94 | MP0004185_abnormal_adipocyte_glucose | 0.34862084 |
| 95 | MP0005388_respiratory_system_phenotype | 0.34314107 |
| 96 | MP0002133_abnormal_respiratory_system | 0.34314107 |
| 97 | MP0001529_abnormal_vocalization | 0.33435157 |
| 98 | MP0005319_abnormal_enzyme/_coenzyme | 0.33389732 |
| 99 | MP0001727_abnormal_embryo_implantation | 0.31771515 |
| 100 | MP0000013_abnormal_adipose_tissue | 0.31093546 |
| 101 | MP0003935_abnormal_craniofacial_develop | 0.30804010 |
| 102 | MP0002971_abnormal_brown_adipose | 0.30500405 |
| 103 | MP0000534_abnormal_ureter_morphology | 0.29475173 |
| 104 | MP0002078_abnormal_glucose_homeostasis | 0.29321471 |
| 105 | MP0005535_abnormal_body_temperature | 0.28597658 |
| 106 | MP0005551_abnormal_eye_electrophysiolog | 0.26900844 |
| 107 | MP0002295_abnormal_pulmonary_circulatio | 0.26888048 |
| 108 | MP0005171_absent_coat_pigmentation | 0.26795767 |
| 109 | MP0003705_abnormal_hypodermis_morpholog | 0.26400967 |
| 110 | MP0003385_abnormal_body_wall | 0.25971066 |
| 111 | MP0003115_abnormal_respiratory_system | 0.25842855 |
| 112 | MP0005386_behavior/neurological_phenoty | 0.25687050 |
| 113 | MP0004924_abnormal_behavior | 0.25687050 |
| 114 | MP0000372_irregular_coat_pigmentation | 0.25468501 |
| 115 | MP0000537_abnormal_urethra_morphology | 0.24392310 |
| 116 | MP0001175_abnormal_lung_morphology | 0.22512740 |
| 117 | MP0005332_abnormal_amino_acid | 0.22498088 |
| 118 | MP0001299_abnormal_eye_distance/ | 0.22372523 |
| 119 | MP0009697_abnormal_copulation | 0.21992329 |
| 120 | MP0001486_abnormal_startle_reflex | 0.21792287 |
| 121 | MP0000762_abnormal_tongue_morphology | 0.21698866 |
| 122 | MP0003878_abnormal_ear_physiology | 0.21016339 |
| 123 | MP0005377_hearing/vestibular/ear_phenot | 0.21016339 |
| 124 | MP0001697_abnormal_embryo_size | 0.20825960 |
| 125 | MP0002090_abnormal_vision | 0.20458708 |
| 126 | MP0009745_abnormal_behavioral_response | 0.18883930 |
| 127 | MP0002822_catalepsy | 0.18225443 |
| 128 | MP0000427_abnormal_hair_cycle | 0.18098451 |
| 129 | MP0008569_lethality_at_weaning | 0.17310421 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sudden death (HP:0001699) | 7.80346030 |
| 2 | Ventricular tachycardia (HP:0004756) | 7.16618172 |
| 3 | Atrial fibrillation (HP:0005110) | 6.82987533 |
| 4 | Exercise-induced muscle cramps (HP:0003710) | 6.41970599 |
| 5 | Primary atrial arrhythmia (HP:0001692) | 6.37757898 |
| 6 | Supraventricular tachycardia (HP:0004755) | 6.16545755 |
| 7 | Supraventricular arrhythmia (HP:0005115) | 6.01505403 |
| 8 | Calf muscle hypertrophy (HP:0008981) | 5.93822961 |
| 9 | Lipoatrophy (HP:0100578) | 5.75438856 |
| 10 | Syncope (HP:0001279) | 5.41618091 |
| 11 | Right ventricular cardiomyopathy (HP:0011663) | 5.41190421 |
| 12 | Muscle hypertrophy of the lower extremities (HP:0008968) | 5.30533693 |
| 13 | Myoglobinuria (HP:0002913) | 5.16355073 |
| 14 | Exercise-induced myalgia (HP:0003738) | 5.00025737 |
| 15 | Abnormality of the calf musculature (HP:0001430) | 4.87163023 |
| 16 | Palpitations (HP:0001962) | 4.73634394 |
| 17 | Dilated cardiomyopathy (HP:0001644) | 4.58262948 |
| 18 | Ventricular arrhythmia (HP:0004308) | 4.45170379 |
| 19 | Bundle branch block (HP:0011710) | 4.37371068 |
| 20 | Hyporeflexia of lower limbs (HP:0002600) | 4.32574142 |
| 21 | Prolonged QT interval (HP:0001657) | 4.21225796 |
| 22 | Abnormality of the left ventricular outflow tract (HP:0011103) | 4.18904060 |
| 23 | Subaortic stenosis (HP:0001682) | 4.18904060 |
| 24 | Muscle fiber splitting (HP:0003555) | 4.16857020 |
| 25 | Rhabdomyolysis (HP:0003201) | 4.07558433 |
| 26 | Heart block (HP:0012722) | 3.79740089 |
| 27 | EMG: myopathic abnormalities (HP:0003458) | 3.75568656 |
| 28 | Acute necrotizing encephalopathy (HP:0006965) | 3.74518169 |
| 29 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.73305285 |
| 30 | Abnormal atrioventricular conduction (HP:0005150) | 3.54773439 |
| 31 | Ventricular fibrillation (HP:0001663) | 3.47868843 |
| 32 | Atrioventricular block (HP:0001678) | 3.40652776 |
| 33 | Hepatic necrosis (HP:0002605) | 3.35817706 |
| 34 | EMG: neuropathic changes (HP:0003445) | 3.32653001 |
| 35 | Left ventricular hypertrophy (HP:0001712) | 3.27346202 |
| 36 | Increased serum pyruvate (HP:0003542) | 3.25336471 |
| 37 | Abnormality of glycolysis (HP:0004366) | 3.25336471 |
| 38 | Asymmetric septal hypertrophy (HP:0001670) | 3.20809279 |
| 39 | Hypoglycemic coma (HP:0001325) | 3.16717274 |
| 40 | Acute encephalopathy (HP:0006846) | 3.16406334 |
| 41 | Progressive macrocephaly (HP:0004481) | 3.12147519 |
| 42 | Abnormal EKG (HP:0003115) | 3.08574696 |
| 43 | Type 1 muscle fiber predominance (HP:0003803) | 2.99800788 |
| 44 | Mitochondrial inheritance (HP:0001427) | 2.91440701 |
| 45 | Palmoplantar keratoderma (HP:0000982) | 2.89525136 |
| 46 | Increased CSF lactate (HP:0002490) | 2.88296649 |
| 47 | Ragged-red muscle fibers (HP:0003200) | 2.87256466 |
| 48 | Cerebral edema (HP:0002181) | 2.81767032 |
| 49 | Conjunctival hamartoma (HP:0100780) | 2.79651682 |
| 50 | Hepatocellular necrosis (HP:0001404) | 2.76737072 |
| 51 | Hip contracture (HP:0003273) | 2.74157000 |
| 52 | Exercise intolerance (HP:0003546) | 2.72141317 |
| 53 | Distal lower limb muscle weakness (HP:0009053) | 2.71452726 |
| 54 | Increased connective tissue (HP:0009025) | 2.70420244 |
| 55 | Pheochromocytoma (HP:0002666) | 2.67023786 |
| 56 | Abnormality of alanine metabolism (HP:0010916) | 2.64091278 |
| 57 | Hyperalaninemia (HP:0003348) | 2.64091278 |
| 58 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.64091278 |
| 59 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.60790886 |
| 60 | Ketoacidosis (HP:0001993) | 2.54896908 |
| 61 | Muscle fiber inclusion bodies (HP:0100299) | 2.51461702 |
| 62 | Steppage gait (HP:0003376) | 2.47611141 |
| 63 | Dicarboxylic aciduria (HP:0003215) | 2.47421195 |
| 64 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.47421195 |
| 65 | Congenital malformation of the right heart (HP:0011723) | 2.45534075 |
| 66 | Double outlet right ventricle (HP:0001719) | 2.45534075 |
| 67 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.43540116 |
| 68 | Neoplasm of the adrenal gland (HP:0100631) | 2.41196195 |
| 69 | Neuroendocrine neoplasm (HP:0100634) | 2.40678015 |
| 70 | Lactic acidosis (HP:0003128) | 2.40375255 |
| 71 | Nemaline bodies (HP:0003798) | 2.37029633 |
| 72 | Muscular dystrophy (HP:0003560) | 2.37019615 |
| 73 | Respiratory failure (HP:0002878) | 2.33151345 |
| 74 | Increased muscle lipid content (HP:0009058) | 2.29622809 |
| 75 | Hypoplastic left heart (HP:0004383) | 2.29349613 |
| 76 | Myotonia (HP:0002486) | 2.28985404 |
| 77 | Generalized aminoaciduria (HP:0002909) | 2.25961645 |
| 78 | Difficulty running (HP:0009046) | 2.25051268 |
| 79 | Patent foramen ovale (HP:0001655) | 2.23202219 |
| 80 | Diaphragmatic weakness (HP:0009113) | 2.18970198 |
| 81 | Esophageal neoplasm (HP:0100751) | 2.17826898 |
| 82 | Neoplasm of head and neck (HP:0012288) | 2.17826898 |
| 83 | Areflexia of lower limbs (HP:0002522) | 2.15578333 |
| 84 | Neck muscle weakness (HP:0000467) | 2.13297123 |
| 85 | Sudden cardiac death (HP:0001645) | 2.12687502 |
| 86 | Increased intramyocellular lipid droplets (HP:0012240) | 2.11867060 |
| 87 | Limited hip movement (HP:0008800) | 2.11431107 |
| 88 | Rimmed vacuoles (HP:0003805) | 2.10742837 |
| 89 | Bicuspid aortic valve (HP:0001647) | 2.07898183 |
| 90 | Lipid accumulation in hepatocytes (HP:0006561) | 2.06059568 |
| 91 | Congestive heart failure (HP:0001635) | 2.03557426 |
| 92 | Nausea (HP:0002018) | 2.00234610 |
| 93 | Bradycardia (HP:0001662) | 1.99665975 |
| 94 | Generalized muscle weakness (HP:0003324) | 1.98429969 |
| 95 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.93844553 |
| 96 | Muscle stiffness (HP:0003552) | 1.91479236 |
| 97 | Hyperglycemia (HP:0003074) | 1.88274701 |
| 98 | Hamartoma of the eye (HP:0010568) | 1.87586365 |
| 99 | Abnormality of the foot musculature (HP:0001436) | 1.85299204 |
| 100 | Hypoplastic heart (HP:0001961) | 1.80108464 |
| 101 | Dysmetric saccades (HP:0000641) | 1.79139790 |
| 102 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.78556565 |
| 103 | Increased serum lactate (HP:0002151) | 1.78471430 |
| 104 | Tinnitus (HP:0000360) | 1.77246352 |
| 105 | Increased hepatocellular lipid droplets (HP:0006565) | 1.75664985 |
| 106 | Renal cortical cysts (HP:0000803) | 1.75059889 |
| 107 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.74827551 |
| 108 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.74827551 |
| 109 | Foot dorsiflexor weakness (HP:0009027) | 1.73226642 |
| 110 | Ketosis (HP:0001946) | 1.72911051 |
| 111 | Childhood onset (HP:0011463) | 1.72616959 |
| 112 | Gowers sign (HP:0003391) | 1.71067437 |
| 113 | Toxemia of pregnancy (HP:0100603) | 1.69384925 |
| 114 | Proximal tubulopathy (HP:0000114) | 1.68425901 |
| 115 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.65892144 |
| 116 | Increased variability in muscle fiber diameter (HP:0003557) | 1.58744666 |
| 117 | Skin pits (HP:0100276) | 1.57766138 |
| 118 | Periauricular skin pits (HP:0100277) | 1.55536552 |
| 119 | Preauricular pit (HP:0004467) | 1.55536552 |
| 120 | Frequent falls (HP:0002359) | 1.53241175 |
| 121 | Central scotoma (HP:0000603) | 1.49480312 |
| 122 | Abnormality of the endocardium (HP:0004306) | 1.48984318 |
| 123 | Abnormality of the tricuspid valve (HP:0001702) | 1.46534055 |
| 124 | Scapular winging (HP:0003691) | 1.45569459 |
| 125 | Abnormality of the ischium (HP:0003174) | 1.43286491 |
| 126 | Vitreoretinal degeneration (HP:0000655) | 1.42847913 |
| 127 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.42783199 |
| 128 | Knee flexion contracture (HP:0006380) | 1.37581614 |
| 129 | Proximal amyotrophy (HP:0007126) | 1.35693910 |
| 130 | Aplasia of the musculature (HP:0100854) | 1.34099433 |
| 131 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.31746158 |
| 132 | Acanthocytosis (HP:0001927) | 1.28329771 |
| 133 | Papillary thyroid carcinoma (HP:0002895) | 1.28314910 |
| 134 | Late onset (HP:0003584) | 1.27355007 |
| 135 | Progressive muscle weakness (HP:0003323) | 1.27129272 |
| 136 | Pulmonary artery stenosis (HP:0004415) | 1.26650501 |
| 137 | Abnormal ventriculo-arterial connection (HP:0011563) | 1.25967643 |
| 138 | Transposition of the great arteries (HP:0001669) | 1.25967643 |
| 139 | Abnormal connection of the cardiac segments (HP:0011545) | 1.25967643 |
| 140 | Aneurysm (HP:0002617) | 1.25276352 |
| 141 | Skin nodule (HP:0200036) | 1.24625086 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 6.83222604 |
| 2 | MYLK | 4.80255162 |
| 3 | TTN | 4.19275702 |
| 4 | STK24 | 3.45432658 |
| 5 | PDK3 | 3.25141746 |
| 6 | PDK4 | 3.25141746 |
| 7 | DMPK | 3.20147502 |
| 8 | PKN2 | 3.14799810 |
| 9 | LMTK2 | 3.03670917 |
| 10 | PIK3CA | 2.78747296 |
| 11 | PHKG2 | 2.65289907 |
| 12 | PHKG1 | 2.65289907 |
| 13 | TIE1 | 2.30127269 |
| 14 | ZAK | 2.28364551 |
| 15 | FRK | 2.24152717 |
| 16 | BCKDK | 1.99695925 |
| 17 | STK38L | 1.96468722 |
| 18 | GRK7 | 1.91327611 |
| 19 | PDK2 | 1.87508508 |
| 20 | NEK1 | 1.76587965 |
| 21 | MUSK | 1.69433449 |
| 22 | ILK | 1.48606795 |
| 23 | PINK1 | 1.47556368 |
| 24 | LIMK1 | 1.42764679 |
| 25 | CAMK2D | 1.34066447 |
| 26 | CDC42BPA | 1.30973124 |
| 27 | PAK3 | 1.29442555 |
| 28 | WNK4 | 1.25865569 |
| 29 | STK4 | 1.21630311 |
| 30 | TRIB3 | 1.20973138 |
| 31 | FLT3 | 1.20458035 |
| 32 | TRPM7 | 1.16303396 |
| 33 | INSRR | 1.12073776 |
| 34 | PTK2B | 1.11584120 |
| 35 | MARK1 | 1.06794037 |
| 36 | ROCK1 | 1.05299084 |
| 37 | PRPF4B | 1.03070003 |
| 38 | PRKD1 | 0.98816768 |
| 39 | AKT3 | 0.95947118 |
| 40 | NEK9 | 0.92715877 |
| 41 | PRKAA2 | 0.90211469 |
| 42 | CAMK1 | 0.89420986 |
| 43 | MAP3K7 | 0.87341520 |
| 44 | STK39 | 0.85648648 |
| 45 | CAMK4 | 0.84609343 |
| 46 | WNK1 | 0.81715307 |
| 47 | DAPK3 | 0.79642629 |
| 48 | TNIK | 0.76499032 |
| 49 | ACVR1B | 0.74787355 |
| 50 | MAPK7 | 0.69221661 |
| 51 | CAMK2A | 0.68792150 |
| 52 | NME2 | 0.68199289 |
| 53 | PRKAA1 | 0.68100974 |
| 54 | MAP3K6 | 0.64716217 |
| 55 | MAPK12 | 0.64259963 |
| 56 | ERBB3 | 0.60982400 |
| 57 | RET | 0.59409808 |
| 58 | EPHA3 | 0.59113813 |
| 59 | BMPR1B | 0.58970358 |
| 60 | PKN1 | 0.58790029 |
| 61 | ROCK2 | 0.58108397 |
| 62 | AKT2 | 0.57506360 |
| 63 | EPHA4 | 0.56054619 |
| 64 | MAP3K5 | 0.56031521 |
| 65 | KDR | 0.53943807 |
| 66 | NLK | 0.53200168 |
| 67 | PDGFRA | 0.51162817 |
| 68 | RPS6KL1 | 0.49584612 |
| 69 | RPS6KC1 | 0.49584612 |
| 70 | EPHB2 | 0.46099733 |
| 71 | CASK | 0.46029373 |
| 72 | MAP2K3 | 0.45702720 |
| 73 | PRKACA | 0.44415633 |
| 74 | STK38 | 0.43836398 |
| 75 | CAMK2G | 0.42881058 |
| 76 | TESK1 | 0.42146466 |
| 77 | PRKACB | 0.41850818 |
| 78 | WNK3 | 0.41461265 |
| 79 | FGFR1 | 0.38078328 |
| 80 | TAOK2 | 0.37985853 |
| 81 | RPS6KA6 | 0.37878057 |
| 82 | RIPK1 | 0.37256706 |
| 83 | LRRK2 | 0.36700818 |
| 84 | PRKCE | 0.35268778 |
| 85 | ITK | 0.35230607 |
| 86 | PRKD3 | 0.35049943 |
| 87 | MAP3K4 | 0.34987681 |
| 88 | CAMK2B | 0.34423262 |
| 89 | BRSK2 | 0.34411161 |
| 90 | PRKACG | 0.34053488 |
| 91 | MAP3K3 | 0.33816581 |
| 92 | STK3 | 0.33308593 |
| 93 | NUAK1 | 0.33055340 |
| 94 | SGK2 | 0.32141114 |
| 95 | MAP2K1 | 0.30606307 |
| 96 | PRKCQ | 0.30270909 |
| 97 | PRKG1 | 0.28389370 |
| 98 | MAPK13 | 0.27776987 |
| 99 | MAPK4 | 0.27413306 |
| 100 | TGFBR2 | 0.25679258 |
| 101 | STK11 | 0.25073040 |
| 102 | PRKG2 | 0.23628945 |
| 103 | PAK2 | 0.23246287 |
| 104 | MAP4K2 | 0.23138780 |
| 105 | RPS6KA1 | 0.21549413 |
| 106 | LATS1 | 0.21435941 |
| 107 | MKNK2 | 0.20723284 |
| 108 | MARK3 | 0.20178583 |
| 109 | MAP2K4 | 0.19158944 |
| 110 | PLK2 | 0.18811394 |
| 111 | UHMK1 | 0.18312525 |
| 112 | MAPK10 | 0.17785676 |
| 113 | LATS2 | 0.17576206 |
| 114 | CCNB1 | 0.17381356 |
| 115 | MAPKAPK3 | 0.17139640 |
| 116 | ADRBK1 | 0.16728863 |
| 117 | FGFR3 | 0.14942330 |
| 118 | SGK1 | 0.13794693 |
| 119 | PLK4 | 0.13613107 |
| 120 | BCR | 0.12540358 |
| 121 | PDK1 | 0.12278314 |
| 122 | EGFR | 0.10729414 |
| 123 | RAF1 | 0.09824712 |
| 124 | PTK6 | 0.09218908 |
| 125 | PIK3CG | 0.08917305 |
| 126 | RPS6KA3 | 0.08483317 |
| 127 | AKT1 | 0.06835650 |
| 128 | PRKCH | 0.06779326 |
| 129 | FER | 0.06734865 |
| 130 | MAP3K10 | 0.05574651 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 5.96980428 |
| 2 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 4.86155454 |
| 3 | Parkinsons disease_Homo sapiens_hsa05012 | 3.99107283 |
| 4 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.89146190 |
| 5 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.83394112 |
| 6 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.62252576 |
| 7 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.61111043 |
| 8 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.35502921 |
| 9 | Alzheimers disease_Homo sapiens_hsa05010 | 2.86646919 |
| 10 | Huntingtons disease_Homo sapiens_hsa05016 | 2.69583706 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.63286986 |
| 12 | Carbon metabolism_Homo sapiens_hsa01200 | 2.62923434 |
| 13 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.47128858 |
| 14 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.44616282 |
| 15 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.41765346 |
| 16 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.36907091 |
| 17 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.05947536 |
| 18 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.83247940 |
| 19 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.73369473 |
| 20 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.72706318 |
| 21 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.57280090 |
| 22 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.55500144 |
| 23 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.54806946 |
| 24 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.27632408 |
| 25 | Viral myocarditis_Homo sapiens_hsa05416 | 1.24144554 |
| 26 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.22614236 |
| 27 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.19465120 |
| 28 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.14537991 |
| 29 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.05748405 |
| 30 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 1.02047610 |
| 31 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.96210639 |
| 32 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.90244752 |
| 33 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.88086270 |
| 34 | Insulin resistance_Homo sapiens_hsa04931 | 0.80810371 |
| 35 | Taste transduction_Homo sapiens_hsa04742 | 0.78351203 |
| 36 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.76072148 |
| 37 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.70716013 |
| 38 | Galactose metabolism_Homo sapiens_hsa00052 | 0.70425648 |
| 39 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.70245046 |
| 40 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.70044450 |
| 41 | Morphine addiction_Homo sapiens_hsa05032 | 0.66424420 |
| 42 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.64262968 |
| 43 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.64119398 |
| 44 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.63540120 |
| 45 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.62844926 |
| 46 | Salivary secretion_Homo sapiens_hsa04970 | 0.61876412 |
| 47 | Focal adhesion_Homo sapiens_hsa04510 | 0.61787038 |
| 48 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.61323884 |
| 49 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.59987972 |
| 50 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.58887379 |
| 51 | Tight junction_Homo sapiens_hsa04530 | 0.58710353 |
| 52 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.58574816 |
| 53 | Mineral absorption_Homo sapiens_hsa04978 | 0.56640532 |
| 54 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.56161494 |
| 55 | Lysine degradation_Homo sapiens_hsa00310 | 0.53732517 |
| 56 | Adherens junction_Homo sapiens_hsa04520 | 0.53122162 |
| 57 | GABAergic synapse_Homo sapiens_hsa04727 | 0.52944682 |
| 58 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.49044753 |
| 59 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.48010545 |
| 60 | Peroxisome_Homo sapiens_hsa04146 | 0.46418254 |
| 61 | Bile secretion_Homo sapiens_hsa04976 | 0.45340137 |
| 62 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.44219757 |
| 63 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.42468182 |
| 64 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.41706706 |
| 65 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.41374557 |
| 66 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.40846138 |
| 67 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.40291743 |
| 68 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.39080067 |
| 69 | Metabolic pathways_Homo sapiens_hsa01100 | 0.38555301 |
| 70 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.36735941 |
| 71 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.35810015 |
| 72 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.35720837 |
| 73 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.34735248 |
| 74 | Melanoma_Homo sapiens_hsa05218 | 0.32652782 |
| 75 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.32224211 |
| 76 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.31766594 |
| 77 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.30956138 |
| 78 | ABC transporters_Homo sapiens_hsa02010 | 0.30925977 |
| 79 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.30036538 |
| 80 | Renin secretion_Homo sapiens_hsa04924 | 0.27612711 |
| 81 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.27338911 |
| 82 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.27257275 |
| 83 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.26952558 |
| 84 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.25969128 |
| 85 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.25918282 |
| 86 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.25048975 |
| 87 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.24978051 |
| 88 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.24833724 |
| 89 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.24709173 |
| 90 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.24497983 |
| 91 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.23207192 |
| 92 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.22638819 |
| 93 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.22496306 |
| 94 | Circadian entrainment_Homo sapiens_hsa04713 | 0.22421316 |
| 95 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.21528081 |
| 96 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.21443416 |
| 97 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.21294329 |
| 98 | Insulin secretion_Homo sapiens_hsa04911 | 0.18521612 |
| 99 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.17058967 |
| 100 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.12574031 |
| 101 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.10463600 |
| 102 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.10377487 |
| 103 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.07524877 |
| 104 | Amoebiasis_Homo sapiens_hsa05146 | 0.04496111 |
| 105 | Circadian rhythm_Homo sapiens_hsa04710 | 0.04287747 |
| 106 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.03105550 |
| 107 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.02002447 |
| 108 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.01365248 |
| 109 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.01092729 |
| 110 | Purine metabolism_Homo sapiens_hsa00230 | -0.0851145 |
| 111 | Endometrial cancer_Homo sapiens_hsa05213 | -0.0801558 |
| 112 | Rap1 signaling pathway_Homo sapiens_hsa04015 | -0.0744571 |
| 113 | RNA degradation_Homo sapiens_hsa03018 | -0.0660029 |
| 114 | Gap junction_Homo sapiens_hsa04540 | -0.0534466 |
| 115 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | -0.0515786 |
| 116 | Pathways in cancer_Homo sapiens_hsa05200 | -0.0458765 |
| 117 | Glycerolipid metabolism_Homo sapiens_hsa00561 | -0.0458253 |
| 118 | Basal cell carcinoma_Homo sapiens_hsa05217 | -0.0391982 |
| 119 | Olfactory transduction_Homo sapiens_hsa04740 | -0.0314576 |
| 120 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0234369 |
| 121 | Fat digestion and absorption_Homo sapiens_hsa04975 | -0.0207275 |
| 122 | Small cell lung cancer_Homo sapiens_hsa05222 | -0.0202411 |
| 123 | Melanogenesis_Homo sapiens_hsa04916 | -0.0181183 |
| 124 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | -0.0180748 |
| 125 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | -0.0073553 |
| 126 | Platelet activation_Homo sapiens_hsa04611 | -0.0056023 |
| 127 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | -0.0004996 |

